Mayim Bialik reports prolonged gastrointestinal symptoms after one dose of an unnamed GLP-1 medication taken for autoimmune symptoms. Her account describes individual intolerance, not the frequency of severe reactions or evidence of autoimmune benefit.

Experts discussing rising breast cancer diagnoses cite both incidence increases and improved detection, alongside persistent concerns about diagnostic delays. The commentary does not establish that more patient-centered care explains the increase.

ACP places estrogen-based therapy first in its pharmacologic pathway for menopausal vasomotor symptoms, with nonhormonal alternatives for contraindications or intolerance. Recommendation strength and evidence certainty vary, and long-term safety evidence remains limited.

Personalized models using wearable data forecast sedentary bouts in women with chronic pelvic pain, primarily endometriosis. Simpler models performed comparably to deep learning, but benefits from prediction-guided movement prompts remain untested.

The American Heart Association has updated infective endocarditis guidance to incorporate the 2023 Duke/ISCVID diagnostic criteria, advanced microbiologic diagnostics, contemporary imaging recommendations, and evolving antimicrobial treatment approaches while emphasizing multidisciplinary management.

A single-case report describes SAFE-SEAL, a percutaneous bailout technique that restored hemostasis after failure of hybrid femoral closure during transfemoral TAVR, suggesting a potential alternative to more invasive rescue strategies when guidewire access has been lost.